• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma.

作者信息

Wang Liang, Chen Xiao-Qin, Xia Zhong-Jun

机构信息

Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Leuk Lymphoma. 2020 Oct;61(10):2502-2506. doi: 10.1080/10428194.2020.1775206. Epub 2020 Jun 6.

DOI:10.1080/10428194.2020.1775206
PMID:32508171
Abstract
摘要

相似文献

1
New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma.老药新用：利妥昔单抗与两种纳米颗粒递送的化疗药物（白蛋白结合型紫杉醇和聚乙二醇化脂质体阿霉素）联合用于治疗复发/难治性弥漫性大B细胞淋巴瘤
Leuk Lymphoma. 2020 Oct;61(10):2502-2506. doi: 10.1080/10428194.2020.1775206. Epub 2020 Jun 6.
2
Combination of albumin-bound paclitaxel and pegylated liposomal doxorubicin is effective in treatment of heavily treated relapsed/refractory diffuse large B-cell lymphoma: a case report.
Leuk Lymphoma. 2013 Nov;54(11):2553-5. doi: 10.3109/10428194.2013.776166. Epub 2013 Mar 27.
3
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).与利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松龙相比，利妥昔单抗、环磷酰胺、非聚乙二醇化脂质体阿霉素、长春新碱和泼尼松龙在弥漫性大B细胞淋巴瘤患者一线治疗中的心脏毒性：奥地利癌症药物治疗工作组[Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14)的一项随机III期研究。
Eur J Cancer. 2016 May;58:112-21. doi: 10.1016/j.ejca.2016.02.004. Epub 2016 Mar 15.
4
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.聚乙二醇化脂质体阿霉素在老年弥漫性大B细胞淋巴瘤患者标准R-CHOP化疗中替代传统阿霉素的开放标签、单臂、II期试验。
Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):152-8. doi: 10.1016/j.clml.2014.09.001. Epub 2014 Sep 28.
5
Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma.
Med Oncol. 2002;19(1):55-8. doi: 10.1385/MO:19:1:55.
6
Efficacy and safety of cyclophosphamide, doxorubicin, vincristine, and prednisone regimen with pegylated liposomal doxorubicin±rituximab in treating diffuse large B-cell lymphoma.环磷酰胺、多柔比星、长春新碱和泼尼松方案联合聚乙二醇化脂质体多柔比星±利妥昔单抗治疗弥漫性大B细胞淋巴瘤的疗效和安全性。
Minerva Med. 2021 Apr;112(2):310-312. doi: 10.23736/S0026-4806.19.06236-0. Epub 2019 Jul 17.
7
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.非聚乙二醇化脂质体阿霉素联合方案治疗弥漫性大B细胞淋巴瘤合并心脏疾病患者。意大利淋巴瘤基金会开展的HEART01 II期试验结果。
Hematol Oncol. 2018 Feb;36(1):68-75. doi: 10.1002/hon.2425. Epub 2017 May 19.
8
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.伊布替尼联合利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松（R-CHOP）治疗初治 CD20 阳性 B 细胞非霍奇金淋巴瘤患者：一项非随机、1b 期研究。
Lancet Oncol. 2014 Aug;15(9):1019-26. doi: 10.1016/S1470-2045(14)70311-0. Epub 2014 Jul 17.
9
Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.接受聚乙二醇化脂质体阿霉素和利妥昔单抗免疫化疗的非霍奇金淋巴瘤患者间质性肺炎的发病率。
Ann Hematol. 2018 Jan;97(1):141-147. doi: 10.1007/s00277-017-3160-1. Epub 2017 Oct 31.
10
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.老年弥漫性大B细胞淋巴瘤患者中，CHOP化疗联合利妥昔单抗与单纯CHOP化疗的比较。
N Engl J Med. 2002 Jan 24;346(4):235-42. doi: 10.1056/NEJMoa011795.

引用本文的文献

1
Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas.恶性淋巴瘤的靶向药物递送与诊疗一体化策略
Cancers (Basel). 2022 Jan 26;14(3):626. doi: 10.3390/cancers14030626.
2
Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes.纳米颗粒克服生理屏障实现静脉递药至淋巴结
Exp Biol Med (Maywood). 2021 Nov;246(22):2358-2371. doi: 10.1177/15353702211010762. Epub 2021 May 6.